UNSPSC 51182000: Androgens and androgen inhibitors

This classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.

UNSPSC 51182000 Androgens and androgen inhibitors, a Class code, identifies pharmaceutical products used to treat hormone-related conditions in state and local health systems, correctional facilities, and public hospitals. The code encompasses both androgen replacement therapies and androgen inhibitor medications prescribed for conditions including testosterone deficiency, prostate cancer, and gender-affirming care. State and local procurement under this code typically involves formulary additions, bulk pharmaceutical purchasing through group purchasing organizations, and recurring supply contracts managed by pharmacy departments within health agencies.

The source provides no recent state and local contract opportunities tagged to this code. Without documentation of active solicitations, geographic spread, issuing-body activity, or representative opportunities, no further characterization of current market activity is supported.